Integre Asset Management’s Gilead Sciences GILD Stock Holding History

Integre Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-17,064	Closed	-$1.38M	–	200
2017 Q3	$1.38M	Buy	17,064 +2,547	+18%	+$195K	0.92%	47
2017 Q2	$1.03M	Buy	+14,517	New	+$966K	0.62%	49
2017 Q1	–	Sell	-11,593	Closed	-$830K	–	125
2016 Q4	$830K	Hold	11,593	–	–	0.27%	70
2016 Q3	$917K	Hold	11,593	–	–	0.28%	68
2016 Q2	$967K	Hold	11,593	–	–	0.34%	60
2016 Q1	$1.06M	Hold	11,593	–	–	0.32%	60
2015 Q4	$1.17M	Hold	11,593	–	–	0.28%	66
2015 Q3	$1.14M	Hold	11,593	–	–	0.27%	68
2015 Q2	$1.36M	Hold	11,593	–	–	0.28%	68
2015 Q1	$1.14M	Buy	11,593 +617	+6%	+$62.7K	0.23%	81
2014 Q4	$1.03M	Buy	+10,976	New	+$1.14M	0.21%	84

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Integre Asset Management's GILD Position: Q4 2017 in Review

Integre Asset Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 17,064 shares — an estimated $1.38M sold.

Integre Asset Management first reported a position in GILD in Q4 2014 and held it in 11 quarters. The position peaked at $1.38M in Q3 2017. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

Integre Asset Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
Integre Asset Management sold 17,064 Gilead Sciences shares in Q4 2017, an estimated $1.38M.
Integre Asset Management first reported a position in Gilead Sciences in Q4 2014 and held it in 11 quarters.
Integre Asset Management's Gilead Sciences position peaked at $1.38M in Q3 2017.
1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Integre Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.